Drug Shortage Report for KETOROLAC TROMETHAMINE INJECTION, USP

Last updated on 2019-01-19 History
Report ID 71575
Drug Identification Number 02244947
Brand name KETOROLAC TROMETHAMINE INJECTION, USP
Common or Proper name Ketorolac Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) KETOROLAC TROMETHAMINE
Strength(s) 30MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR
Packaging size 1mL
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-01-09
Actual start date
Estimated end date
Actual end date 2019-01-18
Shortage status Resolved
Updated date 2019-01-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-01-19 English Compare
v5 2019-01-18 French Compare
v4 2019-01-18 English Compare
v3 2019-01-10 English Compare
v2 2019-01-08 French Compare
v1 2019-01-08 English Compare

Showing 1 to 6 of 6